• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经纤维瘤病患儿的健康监督

Health supervision for children with neurofibromatosis.

作者信息

Hersh Joseph H

出版信息

Pediatrics. 2008 Mar;121(3):633-42. doi: 10.1542/peds.2007-3364.

DOI:10.1542/peds.2007-3364
PMID:18310216
Abstract

Neurofibromatosis 1 is a multisystem disorder that primarily involves the skin and nervous system. Its population prevalence is 1 in 3500. The condition usually is recognized in early childhood, when cutaneous manifestations are apparent. Although neurofibromatosis 1 is associated with marked clinical variability, most affected children do well from the standpoint of their growth and development. Some features of neurofibromatosis 1 are present at birth, and others are age-related abnormalities of tissue proliferation, which necessitate periodic monitoring to address ongoing health and developmental needs and to minimize the risk of serious medical complications. This clinical report provides a review of the clinical criteria needed to establish a diagnosis, the inheritance pattern of neurofibromatosis 1, its major clinical and developmental manifestations, and guidelines for monitoring and providing intervention to maximize the growth, development, and health of an affected child.

摘要

神经纤维瘤病1型是一种多系统疾病,主要累及皮肤和神经系统。其人群患病率为1/3500。该病通常在儿童早期被识别,此时皮肤表现明显。虽然神经纤维瘤病1型具有显著的临床变异性,但从生长发育的角度来看,大多数患病儿童情况良好。神经纤维瘤病1型的一些特征在出生时就存在,其他则是与年龄相关的组织增殖异常,这需要定期监测以满足持续的健康和发育需求,并将严重医疗并发症的风险降至最低。本临床报告回顾了确诊所需的临床标准、神经纤维瘤病1型的遗传模式、其主要临床和发育表现,以及监测和提供干预的指南,以最大限度地促进患病儿童的生长、发育和健康。

相似文献

1
Health supervision for children with neurofibromatosis.神经纤维瘤病患儿的健康监督
Pediatrics. 2008 Mar;121(3):633-42. doi: 10.1542/peds.2007-3364.
2
Health Supervision for Children With Neurofibromatosis Type 1.1 型神经纤维瘤病患儿的健康监督
Pediatrics. 2019 May;143(5). doi: 10.1542/peds.2019-0660.
3
Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants.1型神经纤维瘤病幼儿父母报告的健康相关生活质量:疾病特异性决定因素的影响
J Pediatr. 2007 Aug;151(2):182-6, 186.e1-2. doi: 10.1016/j.jpeds.2007.03.005.
4
Diagnosing neurofibromatosis type I in children.儿童I型神经纤维瘤病的诊断
Nurse Pract. 1997 Apr;22(4):73-6, 79-81.
5
[Neurofibromatosis type 1 in childhood].儿童1型神经纤维瘤病
Tidsskr Nor Laegeforen. 1999 Aug 10;119(18):2653-7.
6
Health supervision for children with neurofibromatosis. American Academy of Pediatrics Committee on Genetics.神经纤维瘤病患儿的健康监督。美国儿科学会遗传学委员会。
Pediatrics. 1995 Aug;96(2 Pt 1):368-72.
7
Perinatal neurofibromatosis: two case reports and review of the literature.围产期神经纤维瘤病:两例病例报告并文献复习。
Am J Perinatol. 2010 Apr;27(4):285-92. doi: 10.1055/s-0029-1241737. Epub 2009 Oct 28.
8
Effects of individualized developmental care in a randomized trial of preterm infants <32 weeks.个体化发育照护对孕周<32周早产儿随机试验的影响
Pediatrics. 2009 Oct;124(4):1021-30. doi: 10.1542/peds.2008-1881. Epub 2009 Sep 28.
9
Early manifestations of neurofibromatosis: diagnosis and management.
Compr Ther. 1982 Oct;8(10):35-40.
10
A guide for monitoring child development in low- and middle-income countries.低收入和中等收入国家儿童发育监测指南。
Pediatrics. 2008 Mar;121(3):e581-9. doi: 10.1542/peds.2007-1771.

引用本文的文献

1
A Lesson Learned in Managing Traumatic Cervical Neurofibromatosis Type 1.1型创伤性颈神经纤维瘤病治疗中的经验教训
Cureus. 2025 Mar 14;17(3):e80584. doi: 10.7759/cureus.80584. eCollection 2025 Mar.
2
Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects.1型神经纤维瘤病相关视路胶质瘤:当前挑战与未来前景
Cancer Manag Res. 2023 Jul 13;15:667-681. doi: 10.2147/CMAR.S362678. eCollection 2023.
3
Pediatric Eye Evaluations Preferred Practice Pattern.儿科眼科评估首选实践模式
Ophthalmology. 2023 Mar;130(3):P222-P270. doi: 10.1016/j.ophtha.2022.10.030. Epub 2022 Dec 19.
4
Current update on the visual outcome of optic pathway glioma associated with neurofibromatosis type-1.1型神经纤维瘤病相关视路胶质瘤视觉预后的最新进展
Front Surg. 2022 Sep 2;9:908573. doi: 10.3389/fsurg.2022.908573. eCollection 2022.
5
Optic Pathway Glioma in Children with Neurofibromatosis Type 1: A Multidisciplinary Entity, Posing Dilemmas in Diagnosis and Management Multidisciplinary Management of Optic Pathway Glioma in Children with Neurofibromatosis Type 1.1型神经纤维瘤病患儿的视路胶质瘤:一个多学科问题,在诊断和治疗中造成困境 1型神经纤维瘤病患儿视路胶质瘤的多学科治疗
Front Surg. 2022 May 3;9:886697. doi: 10.3389/fsurg.2022.886697. eCollection 2022.
6
A Case Series of Plexiform Neurofibroma: The Unusual Presentations and Surgical Challenges.丛状神经纤维瘤病例系列:不寻常的表现及手术挑战
Cureus. 2022 Mar 14;14(3):e23141. doi: 10.7759/cureus.23141. eCollection 2022 Mar.
7
Genetic syndromes predisposing to pediatric brain tumors.易患小儿脑肿瘤的遗传综合征。
Neurooncol Pract. 2021 Feb 13;8(4):375-390. doi: 10.1093/nop/npab012. eCollection 2021 Aug.
8
Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment.1 型神经纤维瘤病丛状神经纤维瘤的影像学评估:基于调查的评估。
Neurology. 2021 Aug 17;97(7 Suppl 1):S111-S119. doi: 10.1212/WNL.0000000000012437. Epub 2021 Jul 6.
9
Contralateral Breast Cancer With Multiple Primary Neoplasms in a Patient With Neurofibromatosis Type 1: A Case Report and Review of the Literature.1型神经纤维瘤病患者伴多原发性肿瘤的对侧乳腺癌:一例报告并文献复习
Cureus. 2021 Mar 6;13(3):e13738. doi: 10.7759/cureus.13738.
10
Genetic predisposition in pediatric oncology.儿童肿瘤学中的遗传易感性。
Med Pharm Rep. 2020 Oct;93(4):323-334. doi: 10.15386/mpr-1576. Epub 2020 Oct 25.